AIM
HSTO

Alambic Investment Management’s Histogen Inc. Common Stock HSTO Stock Holding History

Alambic Investment Management’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-258
Closed -$300K – 395
2018
Q3 		$300K Sell
258
-1,065
-80% -$981K 0.24% 156
2018
Q2 		$1.13M Buy
1,323
+892
+207% +$741K 0.31% 123
2018
Q1 		$506K Sell
431
-82
-16% -$90.6K 0.07% 314
2017
Q4 		$474K Buy
513
+370
+259% +$342K 0.06% 321
2017
Q3 		$156K Buy
143
+37
+35% +$42.1K 0.02% 453
2017
Q2 		$122K Buy
+106
New +$129K 0.01% 531
2016
Q1 		– Sell
-93
Closed -$53K – 538
2015
Q4 		$53K Buy
+93
New +$65.2K 0.03% 355

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return

Alambic Investment Management's HSTO Position: Q4 2018 in Review

Alambic Investment Management sold out of Histogen Inc. Common Stock (HSTO) in Q4 2018, closing a stake of 258 shares — an estimated $300K sold.

Alambic Investment Management first reported a position in HSTO in Q4 2015 and held it in 7 quarters. The position peaked at $1.13M in Q2 2018. 52 funds tracked by Wall St. Rank hold HSTO as of Q4 2018.

  • Alambic Investment Management reported no remaining Histogen Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Alambic Investment Management sold 258 Histogen Inc. Common Stock shares in Q4 2018, an estimated $300K.
  • Alambic Investment Management first reported a position in Histogen Inc. Common Stock in Q4 2015 and held it in 7 quarters.
  • Alambic Investment Management's Histogen Inc. Common Stock position peaked at $1.13M in Q2 2018.
  • 52 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2018.

Based on Alambic Investment Management's 13F filing for Q4 2018, filed 12 Feb 2019.